METAPNEUMOVIRUS INFECTION
Clinical trials for METAPNEUMOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new METAPNEUMOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for METAPNEUMOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA vaccine aims to shield seniors from two dangerous respiratory viruses
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested an experimental mRNA vaccine designed to prevent lower respiratory tract disease caused by RSV and hMPV viruses. About 558 healthy adults aged 18-49 and 60+ received a single shot at different doses. Researchers monitored safety and immune responses …
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:31 UTC
-
Triple-Threat vaccine trial aims to shield seniors from three winter viruses
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested whether a new combination vaccine is safe and helps the body build defenses against three respiratory viruses: RSV, hMPV, and PIV3. About 390 adults aged 60 and older received different doses or combinations of the vaccine. Researchers monitored side…
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:30 UTC